Pharmaceuticals Companies By Working Capital

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Working Capital
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Working CapitalEfficiencyMarket RiskExp Return
1RDY Dr Reddys Laboratories
118.53 B
(0.09)
 1.30 
(0.12)
2BMY Bristol Myers Squibb
9.51 B
(0.09)
 1.58 
(0.15)
3JNJ Johnson Johnson
7.21 B
(0.04)
 0.99 
(0.04)
4MRK Merck Company
6.47 B
 0.06 
 1.06 
 0.06 
5SNY Sanofi ADR
6.46 B
 0.07 
 1.41 
 0.10 
6VTRS Viatris
5.2 B
(0.15)
 1.59 
(0.24)
7ZTS Zoetis Inc
4.45 B
(0.06)
 1.97 
(0.11)
8NVS Novartis AG ADR
4.09 B
 0.10 
 1.00 
 0.10 
9ELAN Elanco Animal Health
2.17 B
 0.04 
 3.63 
 0.13 
10JAZZ Jazz Pharmaceuticals PLC
1.9 B
(0.12)
 1.74 
(0.22)
11OGN Organon Co
1.59 B
 0.17 
 1.76 
 0.30 
12BHC Bausch Health Companies
1.29 B
(0.09)
 2.70 
(0.26)
13PRGO Perrigo Company PLC
1.25 B
(0.01)
 2.94 
(0.03)
14CTLT Catalent
1.17 B
(0.15)
 0.46 
(0.07)
15RPRX Royalty PharmaPlc
1.11 B
(0.07)
 1.19 
(0.09)
16ARVN Arvinas
1.02 B
(0.29)
 2.56 
(0.74)
17TARO Taro Pharmaceutical Industries
950.88 M
 0.01 
 0.54 
 0.01 
18CRON Cronos Group
891.91 M
 0.12 
 4.00 
 0.47 
19HCM HUTCHMED DRC
693.81 M
 0.18 
 3.98 
 0.70 
20ACB Aurora Cannabis
599.89 M
 0.13 
 10.97 
 1.47 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY